SAGE THERAPEUTICS INC shareholders Q2 2023

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 224 filers reported holding SAGE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

SAGE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
AMERIPRISE FINANCIAL INC 890,043$41,849,8210.01%
Cape Investment Advisory, Inc. 500$23,5100.01%
Man Group plc 80,661$3,792,6800.01%
TUDOR INVESTMENT CORP ET AL 20,823$979,0970.01%
China Universal Asset Management Co., Ltd. 783$370.01%
Fisher Asset Management, LLC 431,146$20,272,4840.01%
MetLife Investment Management, LLC 27,683$1,301,6550.01%
MILLENNIUM MANAGEMENT LLC 418,110$19,659,5320.01%
SCHRODER INVESTMENT MANAGEMENT GROUP 150,304$7,067,2940.01%
Walleye Capital LLC 54,561$2,565,4580.01%
Allianz Asset Management GmbH 108,010$5,078,6300.01%
JPMORGAN CHASE & CO 1,692,594$79,585,7700.01%
Westside Investment Management, Inc. 700$32,9140.01%
Cambridge Investment Research Advisors, Inc. 35,573$1,6730.01%
Allspring Global Investments Holdings, LLC 102,643$4,826,2730.01%
AMERICAN CENTURY COMPANIES INC 222,793$10,475,7270.01%
Squarepoint Ops LLC 55,314$2,600,8640.01%
Ameritas Investment Partners, Inc. 4,366$205,2890.01%
Schonfeld Strategic Advisors LLC 20,823$979,0970.01%
State of New Jersey Common Pension Fund D 48,401$2,275,8150.01%
External links

This page lists SAGE THERAPEUTICS INC's shareholders in Q2 2023. To view SAGE THERAPEUTICS INC's shareholder history, click here.